Accessibility Menu
 
Replimune Group logo

Replimune Group

(NASDAQ) REPL

Current Price$8.29
Market Cap$694.44M
Since IPO (2018)-45%
5 Year-73%
1 Year-2%
1 Month+17%

Replimune Group Financials at a Glance

Market Cap

$694.44M

Revenue (TTM)

$0.00

Net Income (TTM)

$314.85M

EPS (TTM)

$-3.58

P/E Ratio

-2.35

Dividend

$0.00

Beta (Volatility)

1.03 (Average)

Price

$8.29

Volume

83,010

Open

$7.67

Previous Close

$8.29

Daily Range

$7.67 - $8.42

52-Week Range

$2.68 - $13.24

REPL: Motley Fool Moneyball Superscore

49

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Replimune Group

Industry

Biotechnology

Employees

479

CEO

Sushil Patel, PhD

Headquarters

Woburn, MA 01801, US

REPL Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-91%

Return on Capital

-1%

Return on Assets

-94%

Earnings Yield

-42.55%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$694.44M

Shares Outstanding

82.57M

Volume

83.01K

Short Interest

0.00%

Avg. Volume

1.47M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$261.63M

EBITDA

$253.92M

Operating Cash Flow

$192.25M

Capital Expenditure

$6.69M

Free Cash Flow

$198.94M

Cash & ST Invst.

$483.80M

Total Debt

$76.17M

Replimune Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$694.44M

N/A

Market Cap/Employee

$1.45M

N/A

Employees

479

N/A

Net Income

$70.93M

-6.9%

EBITDA

$67.95M

-4.6%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Net Cash

$190.28M

-58.7%

Accounts Receivable

$2.96M

-3.6%

Inventory

$0.00

N/A

Long Term Debt

$74.78M

+3.7%

Short Term Debt

$4.08M

+3.3%

Return on Assets

-94.38%

N/A

Return on Invested Capital

-1.15%

N/A

Free Cash Flow

$66.09M

-25.9%

Operating Cash Flow

$65.95M

-30.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARVNArvinas, Inc.
$10.85-4.24%
ATXSAstria Therapeutics, Inc.
$12.58+0.00%
MGTXMeiraGTx Holdings plc
$9.18+0.99%
PRMEPrime Medicine, Inc.
$3.32-2.06%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
INTCIntel
$50.38+0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About REPL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.